Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Log In | Register FREE | Register for Free Webinar | Solution Enquiry | Subscribe
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
Webinar Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Venkat Pharma Ltd Stock Analysis

Small Cap
Evaluated by 46 users | BSE: 532093 | NSE: |
Pharmaceuticals & Drugs
Read More
10YEAR X-RAY

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'10Mar'11Mar'12Mar'13TTM
Return on Capital Employed 03.95%1.32%5.92%04.89%7.16%-1.54%-0.46%-0.24%-0.26%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 019.741.751.9047.836.400000
Y-o-Y Gr. Rt.-NA111.5%24.5%-100%NA-23.9%-100%NANANA-
Adjusted EPS (Rs.) 00.160.080.9400.420.48-0.51-0.13-0.07-0.09-0.05
Y-o-Y Gr. Rt.-NA-50%1075%-100%NA14.3%-206.3%NANANA-
Book Value per Share (Rs.) 010.710.8111.81014.5815.09-4.8-4.93-5-5.09-5.18
Adjusted Net Profit 00.100.300.20.2-0.3-0.1000
Net Op. Cash Flow (Rs. Cr.) 00.9-0.80.30-1.50.30000-
Debt to Cash Flow from Ops 02.74-2.676.510-4.7143.94-6,228.47-12,456.95-1,536.16-14,785.43-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Venkat Pharma Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%-100%NANA
Adjusted EPS -193.8%-173.5%NANA
Book Value per Share -192.1-18100
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'99Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'10Mar'11Mar'12Mar'13TTM
Return on Equity (%) 01.40.718.0303.493.22-11.232.651.481.760.97
Operating Profit Margin (%) 02.690.691.1501.955.300000
Net Profit Margin (%) 00.280.070.6300.40.600000
Debt to Equity 00.670.550.4701.081.78-6.76-6.59-7.7-7.573.85
Working Capital Days 0025120601892400000-
Cash Conversion Cycle 0046460801620000-
Price Chart
Loading price chart...
shareholding patterns

Shareholding Pattern

Entity Percentage Holding
Promoters 22.35%
Non-Institutions 77.65%
shareholding patterns

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
shareholding patterns

FAQs

1. Is Venkat Pharma a good quality company?
Data is not available for this company.
2. Is current market price of Venkat Pharma a good price to buy it?

Data is not available for this company.

3. What is Venkat Pharma share price return in the past 10 years ?

Data is not available for this company

4. Is Venkat Pharma a good long term investment?

Data is not available for this company.

shareholding patterns

About Venkat Pharma

Venkat Pharma Ltd is a public limited company registered under the Indian Companies Act 1956 and their stock is listed in Bombay Stock Exchange (BSE) and is being actively traded. Established in 1989 it started manufacturing & sales of pharma products in 1992. The company is solely into the manufacturing and export of pharmaceutical products since their inception with an unswerving dedication.

At Venkat Pharma they meticulously manufacture pharma products, and constantly improvise

Read More

Venkat Pharma Ltd is a public limited company registered under the Indian Companies Act 1956 and their stock is listed in Bombay Stock Exchange (BSE) and is being actively traded. Established in 1989 it started manufacturing & sales of pharma products in 1992. The company is solely into the manufacturing and export of pharmaceutical products since their inception with an unswerving dedication.

At Venkat Pharma they meticulously manufacture pharma products, and constantly improvise existing product mix, thereby carving out a niche for themselves, in the global playing field of pharma.

Their philosophy is to provide value priced and quality pharmaceutical products to the humankind at large. At Venkat, they believe, that there is no compromise on the health of a human being. Their growth rate is quite above the industry CAGR growth rates as they are growing at a rate of 35% year on year.

Product range of the company includes:

  • API
  • PFIs
  • Finished Dosage
  • Under Development
  • Nutraceuticals

Milestones:

  • Floated as a Pvt. Ltd Company in 1989
  • Entered International Market in 1994
  • Became Public Ltd company in 1995
  • Issued an IPO in 1996
  • Listing in Bombay Stock Exchange in 1997
  • International market expansion via Product Registration Year 2000
  • Started APIs manufacturing in 2001
  • Strengthening of bottom line by trimming down less profitable products & markets in 2002
  • Expansions initiated in Regulated Markets

Achievements/ recognition :

  • It is an ISO 9001: 2000 certified organisation
Read Less
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback